Hypogonadism Completed Phase 2 Trials for Fispemifene (DB06640)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00290134A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of HypogonadismTreatment
NCT00415571Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 InhibitorsTreatment
NCT01061970Efficacy and Safety of Fispemifene in the Treatment of Hypogonadal Men With Chronic Obstructive Pulmonary Disease That Are on Oral Glucocorticoid TherapyTreatment